Sackler family

LONG ISLAND UNIVERSITY TO HONOR 16 LAUREATES IN CELEBRATION OF THE 75TH ANNIVERSARY OF ITS GEORGE POLK AWARDS IN JOURNALISM

Retrieved on: 
Wednesday, January 31, 2024

BROOKVILLE, N.Y., Jan. 31, 2024 /PRNewswire/ -- Long Island University today announced it will mark the 75th anniversary of its George Polk Awards in journalism by honoring 16 individuals whose careers reflect the awards' commitment to outstanding investigative reporting as the first-ever Polk Laureates.

Key Points: 
  • BROOKVILLE, N.Y., Jan. 31, 2024 /PRNewswire/ -- Long Island University today announced it will mark the 75th anniversary of its George Polk Awards in journalism by honoring 16 individuals whose careers reflect the awards' commitment to outstanding investigative reporting as the first-ever Polk Laureates.
  • The event, to be held at Cipriani 42nd Street will be hosted by CNN anchor and CBS 60 Minutes correspondent Anderson Cooper.
  • The Polk Awards were established in 1949 by Long Island University to commemorate George Polk, a CBS correspondent murdered in 1948 while covering the Greek civil war.
  • "Long Island University has long recognized the importance of investigative journalism through the George Polk Awards and our George Polk School of Communications which is helping prepare an international class of the journalists of tomorrow," noted Dr. Kimberly Cline, President of Long Island University.

Netflix’s The Fall of the House of Usher: an incoherent mess of references that fails to honour Edgar Allan Poe

Retrieved on: 
Friday, October 27, 2023

This article contains spoilers Edgar Allan Poe’s “The Fall of the House of Usher” (1839) is one of the most famous short stories in American literature.

Key Points: 
  • This article contains spoilers Edgar Allan Poe’s “The Fall of the House of Usher” (1839) is one of the most famous short stories in American literature.
  • A tale of illness, psychosis and premature burial, the downfall of Roderick and Madeline Usher has horrified readers for generations.
  • However, The Fall of the House of Usher incessantly remixes, grafts and merges references to Poe’s work to confusing effect.

Drowning in pointless references

  • The references to Poe, which are initially fun and engaging to identify, quickly become exasperating and exhausting to endure.
  • For example, the names of each of the Usher children – Frederick, Tamerlane, Victorine, Camille, Napoleon and Prospero – are taken from several tales and poems.
  • These include “Metzingerstein,” “The Premature Burial,” “Tamerlane,” “The Murders in the Rue Morgue,” “The Spectacles,” and “The Masque of the Red Death.” Beyond featuring in these stories, these references largely lack real sense of purpose.

Two saving graces

  • These episodes are similar in that they centre around the psychological disintegration and violent deaths of Napoleon and Victorine Usher.
  • Like in Poe’s original tales, Napoleon and Victorine are plagued by their wrongdoings.
  • Napoleon is tormented by a cat he gets to replace an identical-looking one he had accidentally killed.
  • Driven to madness by the feline he goes on a destructive rampage and manages to kill himself.


Looking for something good? Cut through the noise with a carefully curated selection of the latest releases, live events and exhibitions, straight to your inbox every fortnight, on Fridays. Sign up here.
Dr Ahmed Honeini had received funding from the Society of Authors. He works for Royal Holloway, University of London and the Journal of American Studies. He is affiliated with the British Association for American Studies.

 Purdue Pharma L.P. Announces Preliminary Voting Results on Plan of Reorganization

Retrieved on: 
Tuesday, July 27, 2021

Purdue Pharma L.P. today announced preliminary voting results that show overwhelming support for its chapter 11 plan of reorganization (The Plan).

Key Points: 
  • Purdue Pharma L.P. today announced preliminary voting results that show overwhelming support for its chapter 11 plan of reorganization (The Plan).
  • Out of almost 5,000 state and local governmental creditors, almost 97% voted to accept the plan.
  • The preliminary voting results demonstrate a broad consensus among every organized creditor group in these proceedings, and we will continue to work for even greater consensus ahead of the confirmation hearings.
  • Purdue expects to make public the final voting results by August 2, but the tally is not expected to change materially from these preliminary results.

Evoke Pharma Launches Gimoti® Patient and Physician Experience Program

Retrieved on: 
Wednesday, July 14, 2021

The program intends to expand awareness and trial of GIMOTI for both physicians and patients and help both groups gain experience with GIMOTI and its non-oral treatment benefits.

Key Points: 
  • The program intends to expand awareness and trial of GIMOTI for both physicians and patients and help both groups gain experience with GIMOTI and its non-oral treatment benefits.
  • We are pleased to announce the launch of the GIMOTI patient and physician experience program.
  • This is an important opportunity to provide GIMOTI directly to physicians who havent prescribed GIMOTI and increase trial among patients with DGP who seek an alternative approach to traditional oral medications, commented David Gonyer, R.Ph., Evoke Pharma President and CEO.
  • Follow Evoke Pharma on Facebook: https://www.facebook.com/Evoke-Pharma-Inc-131313647029724
    Follow Evoke Pharma on LinkedIn: https://www.linkedin.com/company/evoke-pharma/
    Evoke cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements.

If You Think You Were Harmed By Hydrocodone, Oxycodone, Roxicodone, Codeine, Or Other Opioid Pain Medication

Retrieved on: 
Friday, June 25, 2021

Mallinckrodt is a manufacturer of opioid pain medication that filed for chapter 11 bankruptcy in October 2020.

Key Points: 
  • Mallinckrodt is a manufacturer of opioid pain medication that filed for chapter 11 bankruptcy in October 2020.
  • These opioid trusts will be established for the purpose of distributing money to individuals and corporate entities holding Opioid Claims and for abatement of the opioid crisis.
  • There is nothing you need to do right now to assert your Opioid Claim.
  • You will be notified of how to assert your Opioid Claim against an opioid trust at a later date.

Did You File a Claim Against Purdue Pharma as Part of its Bankruptcy Proceeding? Do You have a Claim Against Purdue Pharma's Owners?

Retrieved on: 
Wednesday, June 16, 2021

NEW YORK, June 16, 2021 /PRNewswire/ --The following statement is being issued by Prime Clerk* regarding the Purdue Pharma L.P. bankruptcy.

Key Points: 
  • NEW YORK, June 16, 2021 /PRNewswire/ --The following statement is being issued by Prime Clerk* regarding the Purdue Pharma L.P. bankruptcy.
  • The Court will consider confirmation of the plan at the Confirmation Hearing.
  • Detailed instructions on how to vote are available at PurduePharmaClaims.comor by calling (844) 217-0912 (toll free) or (347) 859-8093 (international).
  • To do so, you must file a motion with the Court on or beforeJuly 19, 2021, at 4:00 p.m., prevailing Eastern Time.

Did You File a Claim Against Purdue Pharma as Part of its Bankruptcy Proceeding? Do You have a Claim Against Purdue Pharma's Owners?

Retrieved on: 
Wednesday, June 16, 2021

NEW YORK, June 16, 2021 /PRNewswire/ --The following statement is being issued by Prime Clerk* regarding the Purdue Pharma L.P. bankruptcy.

Key Points: 
  • NEW YORK, June 16, 2021 /PRNewswire/ --The following statement is being issued by Prime Clerk* regarding the Purdue Pharma L.P. bankruptcy.
  • The Court will consider confirmation of the plan at the Confirmation Hearing.
  • Detailed instructions on how to vote are available at PurduePharmaClaims.comor by calling (844) 217-0912 (toll free) or (347) 859-8093 (international).
  • To do so, you must file a motion with the Court on or beforeJuly 19, 2021, at 4:00 p.m., prevailing Eastern Time.

Pinnacle Treatment Centers opens Flemington Treatment Services in New Jersey to provide opioid addiction treatment

Retrieved on: 
Thursday, May 20, 2021

b'RINGOES, N.J., May 20, 2021 /PRNewswire/ -- Pinnacle Treatment Centers , a leader in providing accessible, affordable care for people seeking treatment for opioid use disorder, has opened Flemington Treatment Services in New Jersey.

Key Points: 
  • b'RINGOES, N.J., May 20, 2021 /PRNewswire/ -- Pinnacle Treatment Centers , a leader in providing accessible, affordable care for people seeking treatment for opioid use disorder, has opened Flemington Treatment Services in New Jersey.
  • The coronavirus pandemic is a likely factor as well as fentanyl showing up in many street drugs.\n"The pandemic wreaked havoc on people who were already struggling with the disease of addiction," said Joseph Pritchard , CEO, Pinnacle Treatment Centers.
  • The therapeutic work our patients put in is essential to their recovery," said Christopher Johnston, MD ABPM-ADM, chief medical officer for Pinnacle Treatment Centers and medical director in New Jersey at Pinnacle\'s opioid treatment programs, including Flemington.
  • Individuals can call 908-905-0130 for a free confidential assessment.\nPinnacle\'s 11 addiction treatment centers in New Jersey include:\nHeadquartered in Mount Laurel, New Jersey, Pinnacle Treatment Centers is a recognized leader in comprehensive drug and alcohol addiction treatment serving more than 33,000 patients daily in California ( Aegis Treatment Centers ), Georgia ( HealthQwest ), Indiana, Kentucky, New Jersey, Ohio, Pennsylvania, and Virginia.

Raymond Sackler Family Launches Comprehensive Website To Correct False Narrative About Role In Opioid Crisis

Retrieved on: 
Wednesday, May 19, 2021

b"The Raymond Sackler family today released documents and information (available at the website www.judgeforyourselves.info ) that address the many false allegations blaming family members, Purdue Pharma and OxyContin for creating the tragic opioid crisis in the United States.

Key Points: 
  • b"The Raymond Sackler family today released documents and information (available at the website www.judgeforyourselves.info ) that address the many false allegations blaming family members, Purdue Pharma and OxyContin for creating the tragic opioid crisis in the United States.
  • The website, based entirely on publicly-available documents and data, includes detailed information about the origins of the opioid crisis, which long predated the launch of OxyContin in 1996, and on the FDA\xe2\x80\x99s continuing approval (including to this day) of OxyContin for patients suffering from chronic pain.\nThe interactive website, which allows interested users to search content, includes a series of video presentations based on historical documents and information made public, with the Sacklers\xe2\x80\x99 consent, as part of the Purdue Pharma bankruptcy proceedings.
  • These documents clearly establish that Sackler family members who served on Purdue's board conducted themselves ethically and lawfully at all times.\nThe presentations and information available on the website reveal how the false narratives about the Sackler family and its alleged role in the opioid crisis were orchestrated by plaintiffs\xe2\x80\x99 lawyers, who clearly articulated\xe2\x80\x94and stand to benefit from\xe2\x80\x94their plans to vilify Purdue and the Sackler family.
  • They remain committed to resolutions that will provide substantial resources for addressing the opioid crisis.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210519005818/en/\n"

Purdue Pharma L.P. Files Broadly Supported Plan of Reorganization

Retrieved on: 
Tuesday, March 16, 2021

Purdue Pharma L.P. today filed a Chapter 11 plan of reorganization (the Plan) and a related disclosure statement in the United States Bankruptcy Court for the Southern District of New York.

Key Points: 
  • Purdue Pharma L.P. today filed a Chapter 11 plan of reorganization (the Plan) and a related disclosure statement in the United States Bankruptcy Court for the Southern District of New York.
  • Second, it will dissolve Purdue and transfer its operating assets to a newly formed company with the public-minded mission of addressing the opioid crisis.
  • The FDA approved a generic version of buprenorphine and naloxone tablets developed by Rhodes Pharmaceuticals, a subsidiary of Purdue, in 2020.
  • Following the Bankruptcy Courts approval of the disclosure statement, Purdue will distribute the Plan and disclosure statement to voting creditors for their consideration.